Ads
related to: Novartis
Search results
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 6 days agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 7 hours agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 3 hours agoGoldman Sachs initiated coverage of Medtronic (MDT) with a Sell rating and $83 price target. While...
Goldman Sachs initiates cover on six European pharma stocks By Investing.com
Investing.com· 2 hours agoGoldman Sachs initiates cover on six European pharma stocks
Novartis to seek approvals in two rare kidney diseases after positive Phase 3 trials
Endpoints News· 5 days agoNovartis is building out its rare kidney disease portfolio with two batches of Phase 3 data at the...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
FOX 23 News Albany· 5 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
WJET - WFXP Erie· 5 days ago...atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Zacks· 3 days agoNovartis (NVS) presents data on Fabhalta in adult patients with C3 glomerulopathy and atrasentan in...
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 2 days agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the company in its most recent ...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 8 hours ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...